Trial Profile
Sitagliptin (Januvia) Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 28 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 May 2012 New trial record